NAFLD resolution: 86% in Group A2 vs 74% in Group B2 (p<0.001).   CVD events: 0 in Group A2 vs 5 non-fatal in Group B2 (p=0.024).  Greater LFT normalization in Group A2 (ALT, AST, γ-GT, AP; p<0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.